We reported a positive correlation between the level of UCHL1 in the CSF of MS patients and pro-inflammatory IL-20 and a negative correlation between the concentration of UCHL1 and anti-inflammatory IL-10 in the whole MS cohort and in patients with PMS but not with RRMS. This evidence concerns the gene IL10 and myeloid sarcoma.